Additionally, the question of whether Epithalon's effects are additive or synergistic with other telomere-protective interventions (NAD+ precursors, PARP inhibition, rapamycin) represents a compelling direction for combination research in aging model systems
This cumulative weight loss increased to 8.1% at day 57, indicating a durable pharmacodynamic effect even after the treatment period ended
By reinforcing multiple layers of the gut ecosystem, it supports whole-body wellness from the inside out.1-3,6-9
10.1016/j.humpath.2013.04.009 39 NabetaM.AbeY.KagawaL.HaraguchiR.KitoK.UedaN.et al (2009)
"Switch" studies represent a powerful design option for demonstrating that initial weight loss can be sustained or that further weight loss can be achieved
Figure 35: Diagram showing action of GLP-1, GIP (incretins) and DPP-4 inhibitors, credit: Ilmari Karonen, Wikimedia